A0773

Angiotensin Converting Enzyme Inhibitor

Name: Angiotensin Converting Enzyme Inhibitor
Brand: SIGMA
Price: 38.42 EUR

≥95% (TLC)

Slide 1 of 1

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

1 MG

38,42 €

5 MG

131,75 €

38,42 €

Prezzo di listino45,20 €Risparmia il 15%

Per informazioni sulla disponibilità, contatta il Servizio Clienti.

Richiedi un ordine in blocco

Informazioni su questo articolo

Formula empirica (notazione di Hill):

C₅₃H₇₆N₁₄O₁₂

Numero CAS:

35115-60-7

Peso molecolare:

1101.26

NACRES:

NA.77

PubChem Substance ID:

329770629

UNSPSC Code:

12352200

MDL number:

MFCD00076208

Documenti fondamentali

Visualizza tutta la documentazione

Vai a

Servizio Tecnico

Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.

Permettici di aiutarti

Nome del prodotto

Angiotensin Converting Enzyme Inhibitor, ≥95% (TLC)

InChI key

UUUHXMGGBIUAPW-CSCXCSGISA-N

SMILES string

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@@H]5CCC(=O)N5)C(=O)N6CCC[C@H]6C(=O)N7CCC[C@H]7C(O)=O

InChI

1S/C53H76N14O12/c1-3-29(2)43(51(77)66-25-9-16-39(66)50(76)67-26-10-17-40(67)52(78)79)63-45(71)34(18-20-41(54)68)60-46(72)37-14-7-23-64(37)48(74)35(13-6-22-57-53(55)56)61-47(73)38-15-8-24-65(38)49(75)36(62-44(70)33-19-21-42(69)59-33)27-30-28-58-32-12-5-4-11-31(30)32/h4-5,11-12,28-29,33-40,43,58H,3,6-10,13-27H2,1-2H3,(H2,54,68)(H,59,69)(H,60,72)(H,61,73)(H,62,70)(H,63,71)(H,78,79)(H4,55,56,57)/t29-,33-,34-,35-,36-,37-,38-,39-,40-,43-/m0/s1

biological source

synthetic (organic)

assay

≥95% (TLC)

form

powder

mol wt

~_1.1 kDa

solubility

water: soluble 1 mg/mL, clear, colorless

storage temp.

−20°C

Quality Level

200

Categorie correlate

Bioactive Small Molecule Inhibitors

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 4

Questo articolo	A6185	A0230	P7340
Sigma-Aldrich A0773 Angiotensin Converting Enzyme Inhibitor	Sigma-Aldrich A6185 Calpain Inhibitor I	Sigma-Aldrich A0230 Angiotensin IV trifluoroacetate salt	Sigma-Aldrich P7340 (±)-threo-1-Phenyl-2-decanoylamino-3-morpholino-1-propanol hydrochloride
form powder	form powder	form powder	form powder
assay ≥95% (TLC)	assay ≥97% (TLC)	assay ≥95% (HPLC)	assay ≥98% (TLC)
Quality Level 200	Quality Level 200	Quality Level 100	Quality Level 100
mol wt ~_1.1 kDa	mol wt -	mol wt -	mol wt -
storage temp. −20°C	storage temp. −20°C	storage temp. −20°C	storage temp. −20°C
solubility water: soluble 1 mg/mL, clear, colorless	solubility DMSO: soluble, ethanol: soluble	solubility H₂O: ~1 mg/mL	solubility water: 50 mg/mL, clear, colorless

Classe di stoccaggio

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Of mice and men: therapeutic mTOR inhibition in polycystic kidney disease.

York Pei

Journal of the American Society of Nephrology : JASN, 21(3), 390-391 (2010-02-06)

Structural insights into the specificity of Xyn10B from Paenibacillus barcinonensis and its improved stability by forced protein evolution.

Oscar Gallardo et al.

The Journal of biological chemistry, 285(4), 2721-2733 (2009-11-27)

Paenibacillus barcinonensis is a soil bacterium bearing a complex set of enzymes for xylan degradation, including several secreted enzymes and Xyn10B, one of the few intracellular xylanases reported to date. The crystal structure of Xyn10B has been determined by x-ray

Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies.

Claudia Bello et al.

Bioorganic & medicinal chemistry, 18(9), 3320-3334 (2010-03-30)

Novel alpha-mannosidase inhibitors of the type (2R,3R,4S)-2-({[(1R)-2-hydroxy-1-arylethyl]amino}methyl)pyrrolidine-3,4-diol have been prepared and assayed for their anticancer activities. Compound 30 with the aryl group=4-trifluoromethylbiphenyl inhibits the proliferation of primary cells and cell lines of different origins, irrespective of Bcl-2 expression levels, inducing

The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11.

R Matsas et al.

The Biochemical journal, 223(2), 433-440 (1984-10-15)

Endopeptidase-24.11 (EC 3.4.24.11), purified to homogeneity from pig kidney, was shown to hydrolyse a wide range of neuropeptides, including enkephalins, tachykinins, bradykinin, neurotensin, luliberin and cholecystokinin. The sites of hydrolysis of peptides were identified, indicating that the primary specificity is

A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: common downstream endpoints achieved through disparate therapeutic approaches?

Karly C Sourris et al.

American journal of nephrology, 30(4), 323-335 (2009-06-27)

A commonality among the chemically disparate compounds that inhibit the formation and accumulation of advanced glycation end products (AGEs) or their signalling pathways is their end organ protection in experimental models of diabetes complications. Although this group of therapeutics are

Visualizza tutti i documenti correlati

Domande

Recensioni

Nessuna valutazione

Filtri attivi

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica

Angiotensin Converting Enzyme Inhibitor